A new patent was granted from the Japan Patent Office

Boston, April 19, 2022 – Ab Biosciences, Inc., a biotechnology company developing biologics for chronic inflammatory and autoimmune diseases, today announced that it has received a new patent from the Japan Patent Office (JPO, P7075100).